CN112125827A - A kind of synthetic method for carbonyl-containing steroid compound derivatization reagent - Google Patents
A kind of synthetic method for carbonyl-containing steroid compound derivatization reagent Download PDFInfo
- Publication number
- CN112125827A CN112125827A CN202011065693.4A CN202011065693A CN112125827A CN 112125827 A CN112125827 A CN 112125827A CN 202011065693 A CN202011065693 A CN 202011065693A CN 112125827 A CN112125827 A CN 112125827A
- Authority
- CN
- China
- Prior art keywords
- dioxo
- bromopropoxy
- isoindolinyl
- dione
- isoindoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 27
- -1 steroid compound Chemical class 0.000 title claims abstract description 22
- 238000001212 derivatisation Methods 0.000 title claims abstract description 11
- 238000010189 synthetic method Methods 0.000 title claims description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 title abstract description 21
- QCHIILZRVOHYGP-UHFFFAOYSA-N 2-(3-bromopropoxy)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(OCCCBr)C(=O)C2=C1 QCHIILZRVOHYGP-UHFFFAOYSA-N 0.000 claims abstract description 28
- STXJVEKFPDEMJR-UHFFFAOYSA-M 3-(1,3-dioxoisoindol-2-yl)oxypropyl-trimethylazanium bromide Chemical compound [Br-].O=C1N(C(C2=CC=CC=C12)=O)OCCC[N+](C)(C)C STXJVEKFPDEMJR-UHFFFAOYSA-M 0.000 claims abstract description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 15
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 claims abstract description 14
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000006698 hydrazinolysis reaction Methods 0.000 claims abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 11
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 11
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- FZJRCNLPISUZCV-UHFFFAOYSA-N n-propylpropan-1-amine;hydrobromide Chemical compound Br.CCCNCCC FZJRCNLPISUZCV-UHFFFAOYSA-N 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- JXDNGTCNFHAVIO-UHFFFAOYSA-N n,n-dimethylmethanamine;oxolane Chemical compound CN(C)C.C1CCOC1 JXDNGTCNFHAVIO-UHFFFAOYSA-N 0.000 claims description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims 1
- FCGQIZKUTMUWDC-UHFFFAOYSA-M trimethyl(propyl)azanium;bromide Chemical compound [Br-].CCC[N+](C)(C)C FCGQIZKUTMUWDC-UHFFFAOYSA-M 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000001308 synthesis method Methods 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 abstract description 3
- ICKLSPKTPKWFAP-UHFFFAOYSA-N diazanium;bromide;chloride Chemical compound [NH4+].[NH4+].[Cl-].[Br-] ICKLSPKTPKWFAP-UHFFFAOYSA-N 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- 239000007787 solid Substances 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- UOUIARGWRPHDBX-CQZDKXCPSA-N 19-norandrosterone Chemical compound C1[C@H](O)CC[C@@H]2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 UOUIARGWRPHDBX-CQZDKXCPSA-N 0.000 description 8
- UOUIARGWRPHDBX-UHFFFAOYSA-N 3alpha-Hydroxy-5beta-oestran-17-on Natural products C1C(O)CCC2C3CCC(C)(C(CC4)=O)C4C3CCC21 UOUIARGWRPHDBX-UHFFFAOYSA-N 0.000 description 8
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 235000002597 Solanum melongena Nutrition 0.000 description 6
- 150000003431 steroids Chemical class 0.000 description 6
- QTPOMZUMXZTOMC-UHFFFAOYSA-M 3-aminooxypropyl(trimethyl)azanium bromide Chemical compound C[N+](C)(C)CCCON.[Br-] QTPOMZUMXZTOMC-UHFFFAOYSA-M 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BCYWDUVHAPHGIP-UHFFFAOYSA-N (6-bromopyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC=C(Br)N=C1 BCYWDUVHAPHGIP-UHFFFAOYSA-N 0.000 description 2
- VIGPKJYEYGGCLK-UHFFFAOYSA-N 1-methylimidazole-2-sulfonyl chloride Chemical compound CN1C=CN=C1S(Cl)(=O)=O VIGPKJYEYGGCLK-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- SYNHCENRCUAUNM-UHFFFAOYSA-N Nitrogen mustard N-oxide hydrochloride Chemical compound Cl.ClCC[N+]([O-])(C)CCCl SYNHCENRCUAUNM-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229940081066 picolinic acid Drugs 0.000 description 2
- CDRNYKLYADJTMN-UHFFFAOYSA-N pyridine-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CN=C1 CDRNYKLYADJTMN-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- YDDQOUAKUPMYSD-UHFFFAOYSA-N 1-methyl-2H-pyridine-3-sulfonyl chloride Chemical compound CN1CC(=CC=C1)S(=O)(=O)Cl YDDQOUAKUPMYSD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical group [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 101150073654 dapB gene Proteins 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
- C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Indole Compounds (AREA)
Abstract
本发明涉及一种用于含羰基甾体化合物衍生化试剂的合成方法,属于化学合成技术领域。合成方法为先利用1,3‑二溴丙烷和N‑羟基邻苯二甲酰亚胺反应合成2‑(3‑溴丙氧基)异吲哚啉‑1,3‑二酮;再利用2‑(3‑溴丙氧基)异吲哚啉‑1,3‑二酮制备3‑((1,3‑二氧代‑2‑异吲哚啉基)‑氧基)‑N,N,N‑三甲基丙基溴化铵;最后对3‑((1,3‑二氧代‑2‑异吲哚啉基)‑氧基)‑N,N,N‑三甲基丙基溴化铵进行肼解。本发明的合成方法成本低廉、步骤简单、产率高,能对含羰基甾体化合物进行衍生化,向其中引入永久带电基团‑N+Me3,提高含羰基甾体化合物在ESI‑MS/MS中的检测灵敏度。
The invention relates to a synthesis method for a carbonyl-containing steroid compound derivatization reagent, and belongs to the technical field of chemical synthesis. The synthesis method is to first utilize 1,3-dibromopropane and N-hydroxyphthalimide to react to synthesize 2-(3-bromopropoxy)isoindoline-1,3-dione; and then use 2 -(3-Bromopropoxy)isoindoline-1,3-dione to prepare 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N, N-trimethylpropylammonium bromide; finally to 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl bromide ammonium chloride for hydrazinolysis. The synthesis method of the invention has the advantages of low cost, simple steps and high yield, and can derivatize the carbonyl-containing steroid compound, introduce a permanent charged group-N + Me 3 into it, and improve the ESI-MS/MS/MS ratio of the carbonyl-containing steroid compound. Detection sensitivity in MS.
Description
技术领域technical field
本发明属于化学合成技术领域,更具体地,涉及一种用于含羰基甾体化合物衍生化试剂的合成方法。The invention belongs to the technical field of chemical synthesis, and more particularly relates to a method for synthesizing a derivatizing reagent for carbonyl-containing steroid compounds.
背景技术Background technique
含羰基甾体化合物是一类由内分泌系统分泌并调节代谢过程的非极性化合物,具有重要的生理功能。由于含羰基甾体化合物在生物样品中浓度低,离子化效率差,同分异构体多,其分析面临着巨大挑战。目前分析该类化合物常运用衍生化的策略,在分子中引入可电离的基团可显著提高其灵敏度。常用的衍生化试剂包括丹磺酰氯(DNS-Cl)、吡啶甲酸(PA)、1-甲基咪唑-2-磺酰氯(MLDS)、吡啶-3-磺酰氯(PS)、(3-二甲基氨基苯基)二羟基硼烷(DAPB)、2-溴吡啶-5-硼酸(BPBA)、2-肼吡啶和羟胺。另一种方法是使用季铵衍生物,在分子中引入永久带电基团,以减少ESI源中的电离抑制,例如吉拉德P和吉拉德T试剂、氧胺季铵盐(QAO)试剂和N-甲基吡啶-3-磺酰氯(NMPS)试剂。Carbonyl-containing steroids are a class of non-polar compounds that are secreted by the endocrine system and regulate metabolic processes, and have important physiological functions. Due to the low concentration of carbonyl-containing steroids in biological samples, poor ionization efficiency and many isomers, their analysis faces great challenges. At present, the derivatization strategy is often used to analyze such compounds, and the introduction of ionizable groups in the molecule can significantly improve its sensitivity. Commonly used derivatizing reagents include dansyl chloride (DNS-Cl), picolinic acid (PA), 1-methylimidazole-2-sulfonyl chloride (MLDS), pyridine-3-sulfonyl chloride (PS), (3-dimethylene) aminophenyl) dihydroxyborane (DAPB), 2-bromopyridine-5-boronic acid (BPBA), 2-hydrazinepyridine and hydroxylamine. Another approach is to use quaternary ammonium derivatives that introduce permanently charged groups into the molecule to reduce ionization suppression in ESI sources, such as Girard P and Girard T reagents, quaternary ammonium oxyamine (QAO) reagents and N-methylpyridine-3-sulfonyl chloride (NMPS) reagent.
与吉拉德试剂相比,QAO试剂也可以对羰基进行衍生化,但其检测灵敏度更高。与羟胺相比,QAO试剂衍生化产物稳定性更好,灵敏度更高。因此,QAO试剂广泛用于含羰基甾体化合物的衍生化,然而目前关于其合成方法尚未见报道。Compared with Girard reagent, QAO reagent can also derivatize carbonyl group, but its detection sensitivity is higher. Compared with hydroxylamine, the derivatized product of QAO reagent has better stability and higher sensitivity. Therefore, QAO reagents are widely used in the derivatization of carbonyl-containing steroids, but there is no report on their synthesis.
发明内容SUMMARY OF THE INVENTION
本发明解决了现有技术中含羰基甾体化合物的衍生化试剂衍生化产物稳定性不好以及灵敏度不高的技术问题。本发明的内容是提供一种用于含羰基甾体化合物衍生化试剂的合成方法,用于对含羰基甾体化合物进行衍生化。合成方法为先利用1,3-二溴丙烷和N-羟基邻苯二甲酰亚胺反应合成2-(3-溴丙氧基)异吲哚啉-1,3-二酮;再利用2-(3-溴丙氧基)异吲哚啉-1,3-二酮制备3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵;最后对3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵进行肼解。本发明的合成方法成本低廉、步骤简单、产率高,能对含羰基甾体化合物进行衍生化,向其中引入永久带电基团-N+Me3,提高含羰基甾体化合物在ESI-MS/MS中的检测灵敏度。The invention solves the technical problems of poor stability and low sensitivity of the derivatized product of the carbonyl steroid-containing derivatization reagent in the prior art. The content of the present invention is to provide a synthetic method for derivatizing a carbonyl-containing steroid compound, which is used for derivatizing a carbonyl-containing steroid compound. The synthesis method is to first use 1,3-dibromopropane and N-hydroxyphthalimide to react to synthesize 2-(3-bromopropoxy)isoindoline-1,3-dione; and then use 2 -(3-Bromopropoxy)isoindolin-1,3-dione to prepare 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N, N-trimethylpropylammonium bromide; finally 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl bromide ammonium chloride for hydrazinolysis. The synthesis method of the invention has the advantages of low cost, simple steps and high yield, and can derivatize the carbonyl-containing steroid compound, introduce a permanently charged group -N + Me 3 into it, and improve the ESI-MS/MS/MS ratio of the carbonyl-containing steroid compound. Detection sensitivity in MS.
按照本发明的第一方面,提供了一种用于含羰基甾体化合物衍生化试剂的合成方法,包括以下步骤:According to a first aspect of the present invention, there is provided a method for synthesizing a derivatizing reagent for a carbonyl-containing steroid compound, comprising the following steps:
(1)利用1,3-二溴丙烷和N-羟基邻苯二甲酰亚胺反应合成2-(3-溴丙氧基)异吲哚啉-1,3-二酮;(1) 2-(3-bromopropoxy)isoindoline-1,3-dione is synthesized by the reaction of 1,3-dibromopropane and N-hydroxyphthalimide;
(2)再利用步骤(1)所述的2-(3-溴丙氧基)异吲哚啉-1,3-二酮制备3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵;(2) Reuse 2-(3-bromopropoxy)isoindoline-1,3-dione described in step (1) to prepare 3-((1,3-dioxo-2-isoindoline) dololinyl)-oxy)-N,N,N-trimethylpropylammonium bromide;
(3)在甲醇或四氢呋喃溶液中对步骤(2)所述的3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵进行肼解,即得到式(Ⅰ)所示结构的氧胺季铵盐化合物;(3) 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethyl described in step (2) in methanol or tetrahydrofuran solution The hydrazinolysis is carried out with propyl propyl ammonium bromide to obtain the oxyamine quaternary ammonium salt compound of the structure represented by formula (I);
优选地,步骤(1)中合成2-(3-溴丙氧基)异吲哚啉-1,3-二酮的方法是:将1,3-二溴丙烷与N-羟基邻苯二甲酰亚胺在N,N-二甲基甲酰胺、二甲基亚砜或乙腈中反应,制备得到2-(3-溴丙氧基)异吲哚啉-1,3-二酮;Preferably, the method for synthesizing 2-(3-bromopropoxy)isoindoline-1,3-dione in step (1) is: combining 1,3-dibromopropane with N-hydroxyphthalic acid The imide is reacted in N,N-dimethylformamide, dimethylsulfoxide or acetonitrile to prepare 2-(3-bromopropoxy)isoindoline-1,3-dione;
步骤(2)中利用2-(3-溴丙氧基)异吲哚啉-1,3-二酮制备3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵的方法是:将2-(3-溴丙氧基)异吲哚啉-1,3-二酮与三甲胺反应,得到3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵;In step (2), 2-(3-bromopropoxy) isoindoline-1,3-dione is used to prepare 3-((1,3-dioxo-2-isoindolinyl)-oxygen base)-N,N,N-trimethylpropylammonium bromide method is: react 2-(3-bromopropoxy)isoindoline-1,3-dione with trimethylamine to obtain 3 -((1,3-Dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide;
步骤(3)中在甲醇或四氢呋喃溶液中对3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵进行肼解的方法是:将3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵在甲醇或四氢呋喃溶液中与水合肼反应,得到式(Ⅰ)所示结构的氧胺季铵盐化合物。In step (3), 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl bromide in methanol or tetrahydrofuran solution The method for hydrazinolysis of ammonium is: 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide in methanol Or react with hydrazine hydrate in tetrahydrofuran solution to obtain the oxyamine quaternary ammonium salt compound of the structure represented by formula (I).
优选地,1,3-二溴丙烷与N-羟基邻苯二甲酰亚胺反应的具体方法是:将N-羟基邻苯二甲酰亚胺、1,3-二溴丙烷和三乙胺溶解在N,N-二甲基甲酰胺、二甲基亚砜或乙腈溶剂中,20-30℃条件下搅拌2-20h;其中N-羟基邻苯二甲酰亚胺与1,3-二溴丙烷的物质的量之比为1:(1-2),N-羟基邻苯二甲酰亚胺与三乙胺的物质的量之比为1:(1-2)。Preferably, the specific method for reacting 1,3-dibromopropane with N-hydroxyphthalimide is: mixing N-hydroxyphthalimide, 1,3-dibromopropane and triethylamine Dissolve in N,N-dimethylformamide, dimethylsulfoxide or acetonitrile solvent, and stir at 20-30℃ for 2-20h; in which N-hydroxyphthalimide and 1,3-di The substance amount ratio of bromopropane is 1:(1-2), and the substance amount ratio of N-hydroxyphthalimide and triethylamine is 1:(1-2).
优选地,利用2-(3-溴丙氧基)异吲哚啉-1,3-二酮制备3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵的具体方法是:将2-(3-溴丙氧基)异吲哚啉-1,3-二酮溶解在三甲胺四氢呋喃溶液中,35-50℃条件下搅拌10-20h;其中2-(3-溴丙氧基)异吲哚啉-1,3-二酮与三甲胺的物质的量之比为1:(1-3)。Preferably, 3-((1,3-dioxo-2-isoindolinyl)-oxy) is prepared using 2-(3-bromopropoxy)isoindolin-1,3-dione The specific method of -N,N,N-trimethylpropylammonium bromide is: dissolving 2-(3-bromopropoxy)isoindoline-1,3-dione in trimethylamine tetrahydrofuran solution, Stir at 35-50°C for 10-20h; the ratio of 2-(3-bromopropoxy)isoindoline-1,3-dione to trimethylamine is 1:(1-3) .
优选地,将3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵在甲醇溶液中与水合肼反应的具体方法是:将3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵和水合肼溶解于甲醇或四氢呋喃中,搅拌1-5h;其中3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵与水合肼的物质的量之比为1:(1-5)。Preferably, 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide is mixed with hydrazine hydrate in methanol solution The specific method of the reaction is: dissolving 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide and hydrazine hydrate In methanol or tetrahydrofuran, stirring for 1-5h; wherein 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl bromide The mass ratio of ammonium to hydrazine hydrate is 1:(1-5).
总体而言,通过本发明所构思的以上技术方案与现有技术相比,主要具备以下的技术优点:In general, compared with the prior art, the above technical solutions conceived by the present invention mainly have the following technical advantages:
(1)本合成方法所用的化学试剂成本低廉、合成步骤仅三步、得到衍生化试剂的产率大于80%,有利于高效、快速的生产该衍生化试剂。(1) The chemical reagents used in the synthesis method are of low cost, the synthesis steps are only three steps, and the yield of the derivatized reagent is greater than 80%, which is conducive to the efficient and rapid production of the derivatized reagent.
(2)本发明的衍生化试剂可以有效地对含羰基甾体化合物进行衍生化,向其中引入永久带电基团-N+Me3,提高含羰基甾体化合物在ESI-MS/MS中的检测灵敏度。(2) The derivatization reagent of the present invention can effectively derivatize carbonyl-containing steroids, introduce permanently charged groups -N + Me 3 into them, and improve the detection of carbonyl-containing steroids in ESI-MS/MS sensitivity.
附图说明Description of drawings
图1为按照实施例1的方法制得的衍生化试剂纯化后的1HNMR谱图(400MHz,溶剂为重水D2O)。Fig. 1 is the 1 HNMR spectrum (400 MHz, solvent is deuterium water D 2 O) of the purified derivatizing reagent prepared according to the method of Example 1.
图2和图3分别为按照实施例1的方法制得的衍生化试剂对19-去甲雄酮进行衍生化之后产物的一级质谱图及二级质谱图。FIG. 2 and FIG. 3 are respectively the first-order mass spectrogram and the second-order mass spectrogram of the product after derivatizing 19-norandrosterone by the derivatizing reagent prepared according to the method of Example 1.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。此外,下面所描述的本发明各个实施方式中所涉及到的技术特征只要彼此之间未构成冲突就可以相互组合。In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
本发明化合物表征使用的仪器为:质谱仪为岛津LCMS-2020质谱仪、色谱仪为岛津高效液相色谱仪、核磁共振仪为Bruker 400MHz核磁共振仪。衍生化产物鉴定时使用的仪器为:Thermo Fisher Scientific Q ExactiveTM。含羰基甾体化合物标准品购自Steraloids公司。除特殊说明外,采用的化学试剂均购自Sigma-Aldrich。The instruments used for the characterization of the compounds of the present invention are: the mass spectrometer is a Shimadzu LCMS-2020 mass spectrometer, the chromatograph is a Shimadzu high performance liquid chromatograph, and the nuclear magnetic resonance instrument is a Bruker 400MHz nuclear magnetic resonance instrument. The instrument used for the identification of derivatized products is: Thermo Fisher Scientific Q ExactiveTM. Carbonyl-containing steroid standards were purchased from Steraloids. Unless otherwise specified, the chemical reagents used were purchased from Sigma-Aldrich.
本发明提供的合成含羰基甾体化合物衍生化试剂的反应式如下:The reaction formula of the synthetic carbonyl-containing steroid compound derivatization reagent provided by the invention is as follows:
实施例1Example 1
本发明的含羰基甾体化合物衍生化试剂的合成方法。在50mL茄形瓶中加入N-羟基邻苯二甲酰亚胺(2.01g,12.3mmol),DMF(30mL),1,3-二溴丙烷(2.5mL,24.5mmol)和三乙胺(3.3mL,23.7mmol),于25℃搅拌16h。加水稀释后用乙酸乙酯萃取,有机相经干燥、过滤后柱层析(石油醚/乙酸乙酯=5/1),得到白色固体2-(3-溴丙氧基)异吲哚啉-1,3-二酮2.3g,产率为66%。在48mL封管中加入2-(3-溴丙氧基)异吲哚啉-1,3-二酮(2.3g,8.10mmol),三甲胺四氢呋喃溶液(24mL,24mmol)后于40℃搅拌12h,三甲胺是溶解在四氢呋喃THF里面的。过滤、收集固体,用二氯甲烷洗涤后得白色固体3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵2.36g,产率为85%。在100mL茄形瓶中加入3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵((2.36g,6.88mmol),MeOH(10mL),水合肼(8.09g,13.76mmol),室温搅拌2h。过滤,滤液经浓缩后进一步用乙醇重结晶,得到白色粉末固体3-(氨氧基)-N,N,N-三甲基丙基溴化铵1.30g,产率为80%,分子量为213.1190。图1为按照实施例1的方法制得的衍生化试剂纯化后的1HNMR谱图(400MHz,溶剂为重水D2O)。由图1可知,本发明成功制备了氧胺季铵盐(QAO)化合物。The synthetic method of the carbonyl-containing steroid compound derivatizing reagent of the present invention. In a 50 mL eggplant flask were added N-hydroxyphthalimide (2.01 g, 12.3 mmol), DMF (30 mL), 1,3-dibromopropane (2.5 mL, 24.5 mmol) and triethylamine (3.3 mL, 23.7 mmol), stirred at 25 °C for 16 h. After diluting with water, it was extracted with ethyl acetate. The organic phase was dried, filtered, and subjected to column chromatography (petroleum ether/ethyl acetate = 5/1) to obtain a white solid 2-(3-bromopropoxy)isoindoline- 1,3-Dione 2.3 g, yield 66%. 2-(3-Bromopropoxy)isoindoline-1,3-dione (2.3 g, 8.10 mmol) and trimethylaminetetrahydrofuran solution (24 mL, 24 mmol) were added to a 48 mL sealed tube and stirred at 40°C for 12 h , trimethylamine is dissolved in tetrahydrofuran THF. Filter, collect the solid, wash with dichloromethane to give a white solid 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl Ammonium bromide 2.36 g, yield 85%. In a 100mL eggplant flask, add 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide ((2.36g , 6.88mmol), MeOH (10mL), hydrazine hydrate (8.09g, 13.76mmol), stirred at room temperature for 2h. Filtration, the filtrate was concentrated and further recrystallized with ethanol to obtain a white powder solid 3-(aminooxy)-N, N,N-trimethylpropylammonium bromide 1.30 g, the yield is 80%, and the molecular weight is 213.1190. Figure 1 is the 1 HNMR spectrum of the purified derivatization reagent prepared according to the method of Example 1 (400 MHz, The solvent is heavy water (D 2 O). As can be seen from Figure 1, the present invention has successfully prepared quaternary ammonium oxyamine (QAO) compounds.
实施例2Example 2
本发明的含羰基甾体化合物衍生化试剂的合成方法。在50mL茄形瓶中加入N-羟基邻苯二甲酰亚胺(2.01g,12.3mmol),DMSO(30mL),1,3-二溴丙烷(2.5mL,24.5mmol)和三乙胺(3.3mL,23.7mmol),于20℃搅拌16h。加水稀释后用乙酸乙酯萃取,有机相经干燥、过滤后柱层析(石油醚/乙酸乙酯=5/1),得到白色固体2-(3-溴丙氧基)异吲哚啉-1,3-二酮2.3g,产率为66%。在48mL封管中加入2-(3-溴丙氧基)异吲哚啉-1,3-二酮(2.3g,8.10mmol),三甲胺四氢呋喃溶液(24mL,24mmol)后于35℃搅拌10h。过滤、收集固体,用二氯甲烷洗涤后得白色固体3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵2.36g,产率为85%。在100mL茄形瓶中加入3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵((2.36g,6.88mmol),THF(10mL),水合肼(4.05g,6.88mmol),室温搅拌1h。过滤,滤液经浓缩后进一步用乙醇重结晶,得到白色粉末固体3-(氨氧基)-N,N,N-三甲基丙基溴化铵1.30g,产率为80%,分子量为213.1190。The synthetic method of the carbonyl-containing steroid compound derivatizing reagent of the present invention. In a 50 mL eggplant flask was added N-hydroxyphthalimide (2.01 g, 12.3 mmol), DMSO (30 mL), 1,3-dibromopropane (2.5 mL, 24.5 mmol) and triethylamine (3.3 mL, 23.7 mmol), stirred at 20 °C for 16 h. After diluting with water, it was extracted with ethyl acetate. The organic phase was dried, filtered, and subjected to column chromatography (petroleum ether/ethyl acetate = 5/1) to obtain a white solid 2-(3-bromopropoxy)isoindoline- 1,3-Dione 2.3 g, yield 66%. 2-(3-Bromopropoxy)isoindoline-1,3-dione (2.3 g, 8.10 mmol) and trimethylaminetetrahydrofuran solution (24 mL, 24 mmol) were added to a 48 mL sealed tube and stirred at 35°C for 10 h . Filter, collect the solid, wash with dichloromethane to give a white solid 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl Ammonium bromide 2.36 g, yield 85%. In a 100mL eggplant flask, add 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide ((2.36g , 6.88mmol), THF (10mL), hydrazine hydrate (4.05g, 6.88mmol), stirred at room temperature for 1h. Filtration, the filtrate was concentrated and further recrystallized with ethanol to obtain a white powder solid 3-(aminooxy)-N, N,N-trimethylpropylammonium bromide 1.30 g, the yield is 80%, and the molecular weight is 213.1190.
实施例3Example 3
本发明的含羰基甾体化合物衍生化试剂的合成方法。在50mL茄形瓶中加入N-羟基邻苯二甲酰亚胺(2.01g,12.3mmol),DMF(30mL),1,3-二溴丙烷(2.5mL,24.5mmol)和三乙胺(3.3mL,23.7mmol),于30℃搅拌16h。加水稀释后用乙酸乙酯萃取,有机相经干燥、过滤后柱层析(石油醚/乙酸乙酯=5/1),得到白色固体2-(3-溴丙氧基)异吲哚啉-1,3-二酮2.3g,产率为66%。在48mL封管中加入2-(3-溴丙氧基)异吲哚啉-1,3-二酮(2.3g,8.10mmol),三甲胺四氢呋喃溶液(24mL,24mmol)后于50℃搅拌20h。过滤、收集固体,用二氯甲烷洗涤后得白色固体3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵2.36g,产率为85%。在100mL茄形瓶中加入3-((1,3-二氧代-2-异吲哚啉基)-氧基)-N,N,N-三甲基丙基溴化铵((2.36g,6.88mmol),MeOH(10mL),水合肼(20.2g,34.4mmol),室温搅拌5h。过滤,滤液经浓缩后进一步用乙醇重结晶,得到白色粉末固体3-(氨氧基)-N,N,N-三甲基丙基溴化铵1.30g,产率为80%,分子量为213.1190。The synthetic method of the carbonyl-containing steroid compound derivatizing reagent of the present invention. In a 50 mL eggplant flask were added N-hydroxyphthalimide (2.01 g, 12.3 mmol), DMF (30 mL), 1,3-dibromopropane (2.5 mL, 24.5 mmol) and triethylamine (3.3 mL, 23.7 mmol), stirred at 30 °C for 16 h. After diluting with water, it was extracted with ethyl acetate. The organic phase was dried, filtered, and subjected to column chromatography (petroleum ether/ethyl acetate = 5/1) to obtain a white solid 2-(3-bromopropoxy)isoindoline- 1,3-Dione 2.3 g, yield 66%. 2-(3-Bromopropoxy)isoindoline-1,3-dione (2.3 g, 8.10 mmol) and trimethylaminetetrahydrofuran solution (24 mL, 24 mmol) were added to a 48 mL sealed tube, and the mixture was stirred at 50°C for 20 h . Filter, collect the solid, wash with dichloromethane to give a white solid 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropyl Ammonium bromide 2.36 g, yield 85%. In a 100mL eggplant flask, add 3-((1,3-dioxo-2-isoindolinyl)-oxy)-N,N,N-trimethylpropylammonium bromide ((2.36g , 6.88mmol), MeOH (10mL), hydrazine hydrate (20.2g, 34.4mmol), stirred at room temperature for 5h. Filtration, the filtrate was concentrated and further recrystallized with ethanol to obtain a white powder solid 3-(aminooxy)-N, N,N-trimethylpropylammonium bromide 1.30 g, the yield is 80%, and the molecular weight is 213.1190.
实施例4Example 4
在3ml的透明玻璃瓶中加入3-(氨氧基)-N,N,N-三甲基丙基溴化铵(16.98mg),甲醇(1613μL),乙酸(85μL)于室温下涡旋混匀,配制为10.00mg/mL的溶液。3ml的透明玻璃瓶中加入19-去甲雄酮(1.00mg),DMSO(1.00mL),超声、涡旋至全部溶解,配制为浓度为1.00mg/mL的储备液。5mL的透明玻璃瓶中加入乙腈(2450μL)19-去甲雄酮储备液(1.00mg/mL,50μL)得到19-去甲雄酮浓度为20.00ug/mL的溶液。5mL的透明玻璃瓶中加入乙腈(2450μL)19-去甲雄酮溶液(20.00ug/mL,50μL)得到19-去甲雄酮浓度为40.00ng/mL的工作溶液。精密吸取100μL 9-去甲雄酮溶液于1.5mL离心管中加入19-去甲雄酮工作溶液(40.00ng/mL,100μL),氮气吹干,加入3-(氨氧基)-N,N,N-三甲基丙基溴化铵溶液(10.00mg/mL,50μL),涡旋混匀后,于室温反应1h,加入100μL 70%甲醇,涡旋混匀后,高速离心5min(17000g),取上清液于1.5mL离心管,进行LC-MS分析(进样量为10μL)。3-(Aminooxy)-N,N,N-trimethylpropylammonium bromide (16.98mg), methanol (1613μL), and acetic acid (85μL) were added to a 3ml clear glass bottle and vortexed at room temperature Homogeneous and prepared as a solution of 10.00 mg/mL. 19-norandrosterone (1.00 mg) and DMSO (1.00 mL) were added to a 3 ml transparent glass bottle, sonicated and vortexed until all dissolved, to prepare a stock solution with a concentration of 1.00 mg/mL. Acetonitrile (2450 μL) 19-norandrosterone stock solution (1.00 mg/mL, 50 μL) was added to a 5 mL transparent glass bottle to obtain a solution with a 19-norandrosterone concentration of 20.00 ug/mL. A 19-norandrosterone solution (20.00ug/mL, 50μL) was added in acetonitrile (2450μL) to a 5mL transparent glass bottle to obtain a working solution with a concentration of 40.00ng/mL of 19-norandrosterone. Precisely pipet 100μL of 9-norandrosterone solution into a 1.5mL centrifuge tube, add 19-norandrosterone working solution (40.00ng/mL, 100μL), blow dry with nitrogen, add 3-(aminooxy)-N,N , N-trimethylpropylammonium bromide solution (10.00mg/mL, 50μL), vortex and mix, react at room temperature for 1h, add 100μL of 70% methanol, vortex and mix, and centrifuge at high speed for 5min (17000g) , take the supernatant into a 1.5mL centrifuge tube for LC-MS analysis (the injection volume is 10μL).
使用岛津UPLC/Q-Exactive-MS系统(Thermo Fisher)进行分析。使用ultimateXB-C18 column色谱柱(100mm×2.1mm,1.8μm)。流动相A为水(含0.1%甲酸和10.0mM甲酸铵);流动相B为乙腈。洗脱梯度设定如下:0-0.01min,15%B;0.01-28min,15%-55%B;28-38min,55%-65%B;38-38.1min,65%-90%B;38.1-42min,90%B;42-42.1min,90%-15%B;42.1-45min,15%B。流速设定为0.3mL/min;柱温箱保持在40℃。将等分试样的10μL样品注入UPLC/Q-Exactive-MS系统。MS操作参数设置如下:正离子;源温度为350℃;施加的电源电压为3.5kV;鞘气流速为30arp,辅助气流速为15arp;毛细管温度为300℃。用于MS扫描的m/z为200–800,分辨率为100,000,用于MS/MS扫描的m/z为50-M+50范围,分辨率为500,00。Analysis was performed using a Shimadzu UPLC/Q-Exactive-MS system (Thermo Fisher). An ultimateXB-C18 column column (100 mm×2.1 mm, 1.8 μm) was used. Mobile phase A was water (containing 0.1% formic acid and 10.0 mM ammonium formate); mobile phase B was acetonitrile. The elution gradient was set as follows: 0-0.01min, 15%B; 0.01-28min, 15%-55%B; 28-38min, 55%-65%B; 38-38.1min, 65%-90%B; 38.1-42 min, 90% B; 42-42.1 min, 90%-15% B; 42.1-45 min, 15% B. The flow rate was set at 0.3 mL/min; the column oven was kept at 40°C. An aliquot of 10 μL of sample was injected into the UPLC/Q-Exactive-MS system. The MS operating parameters were set as follows: positive ion; source temperature 350 °C; applied power supply voltage 3.5 kV; sheath gas flow rate 30 arp, auxiliary gas flow rate 15 arp;
原始LC-MS数据以Full Scan-ddMS2正离子模式采集,并使用XcaliburTM4.0软件(Thermo Fisher)进行分析。激素标准品19-去甲雄酮衍生化前后的结构式如下图所示,按照实施例1的方法制得的衍生化试剂对19-去甲雄酮进行衍生化之后产物的一级质谱图及二级质谱图如图2和图3所示,表明所合成的衍生化试剂能够成功将激素衍生化,并被质谱检测到。Raw LC-MS data was acquired in Full Scan-ddMS 2 positive ion mode and analyzed using Xcalibur ™ 4.0 software (Thermo Fisher). The structural formula of the hormone standard 19-norandrosterone before and after derivatization is shown in the figure below. The mass spectrograms of the first stage are shown in Figures 2 and 3, indicating that the synthesized derivatization reagents can successfully derivatize the hormones and detect them by mass spectrometry.
本领域的技术人员容易理解,以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。Those skilled in the art can easily understand that the above are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements and improvements made within the spirit and principles of the present invention, etc., All should be included within the protection scope of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011065693.4A CN112125827A (en) | 2020-09-30 | 2020-09-30 | A kind of synthetic method for carbonyl-containing steroid compound derivatization reagent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011065693.4A CN112125827A (en) | 2020-09-30 | 2020-09-30 | A kind of synthetic method for carbonyl-containing steroid compound derivatization reagent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112125827A true CN112125827A (en) | 2020-12-25 |
Family
ID=73843646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011065693.4A Pending CN112125827A (en) | 2020-09-30 | 2020-09-30 | A kind of synthetic method for carbonyl-containing steroid compound derivatization reagent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112125827A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020349A1 (en) * | 1996-11-05 | 1998-05-14 | Isis Pharmaceuticals, Inc. | Complex chemical libraries |
US6107482A (en) * | 1995-03-27 | 2000-08-22 | Isis Pharmaceuticals, Inc. | Nitrogenous macrocyclic compounds |
US6121433A (en) * | 1990-07-27 | 2000-09-19 | Isis Pharmaceuticals, Inc. | Oligomeric compounds having nitrogen-containing linkages |
WO2011049972A1 (en) * | 2009-10-19 | 2011-04-28 | University Of Louisville Research Foundation, Inc. | Nanoparticles for drug delivery |
CN104040332A (en) * | 2012-01-20 | 2014-09-10 | Dh科技发展私人贸易有限公司 | Analysis of estradiol and analytes with phenolic OH using labeling chemistry and LC-MSMS workflow |
WO2020079614A1 (en) * | 2018-10-16 | 2020-04-23 | Dh Technologies Development Pte. Ltd. | Multiplexed external calibrator and control for screening and diagnostic assays |
WO2020129032A1 (en) * | 2018-12-21 | 2020-06-25 | Dh Technologies Development Pte. Ltd. | Method for measuring testosterone using lc-msms |
-
2020
- 2020-09-30 CN CN202011065693.4A patent/CN112125827A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121433A (en) * | 1990-07-27 | 2000-09-19 | Isis Pharmaceuticals, Inc. | Oligomeric compounds having nitrogen-containing linkages |
US6107482A (en) * | 1995-03-27 | 2000-08-22 | Isis Pharmaceuticals, Inc. | Nitrogenous macrocyclic compounds |
WO1998020349A1 (en) * | 1996-11-05 | 1998-05-14 | Isis Pharmaceuticals, Inc. | Complex chemical libraries |
WO2011049972A1 (en) * | 2009-10-19 | 2011-04-28 | University Of Louisville Research Foundation, Inc. | Nanoparticles for drug delivery |
CN104040332A (en) * | 2012-01-20 | 2014-09-10 | Dh科技发展私人贸易有限公司 | Analysis of estradiol and analytes with phenolic OH using labeling chemistry and LC-MSMS workflow |
WO2020079614A1 (en) * | 2018-10-16 | 2020-04-23 | Dh Technologies Development Pte. Ltd. | Multiplexed external calibrator and control for screening and diagnostic assays |
WO2020129032A1 (en) * | 2018-12-21 | 2020-06-25 | Dh Technologies Development Pte. Ltd. | Method for measuring testosterone using lc-msms |
Non-Patent Citations (3)
Title |
---|
FUMIHIRO ITO等: ""15N-D-labeled ionic probes for mass spe ctrometry"", 《TETRAHEDRON》 * |
MICHAL STAR-WEINSTOCK等: ""LC-ESI-MS/MS Analysis of Testosterone at Sub-Picogram Levels Using a Novel Derivatization Reagent"", 《ANAL. CHEM.》 * |
PRALHAD NAMDEV JOSHI等: ""Single-site labeling of histidine in proteins, on-demand reversibility, and traceless metal-free protein purification"", 《CHEM. COMMUN.》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lan et al. | A simple liquid chromatography tandem mass spectrometric method for fast detection of hydrogen sulfide based on thiolysis of 7-nitro-2, 1, 3-benzoxadiazole ether | |
Wallgren et al. | Synthesis and identifications of potential metabolites as biomarkers of the synthetic cannabinoid AKB-48 | |
CN102603707B (en) | 2,3,4,5,-tetra(3',4'-dihydroxyl phenyl)thiophene and application thereof as MALDI (matrix assisted laser desorption ionization) matrix in analyzing small molecules | |
CN112697897B (en) | A class of derivatization reagents and their applications | |
CN112125827A (en) | A kind of synthetic method for carbonyl-containing steroid compound derivatization reagent | |
CN108794489B (en) | Derivatization reagent and preparation method and application thereof | |
CN114773254A (en) | Quaternary ammonium salt compound or its salt, and its use, method for distinguishing 2-position hydroxyl substituted fatty acid from 3-position hydroxyl substituted fatty acid | |
CN105037359B (en) | A kind of have the half flower compound of cyanines-naphthalimide structure, its preparation method and application | |
CN102531924B (en) | N-(1-naphthyl) ethylenediamine dinitrate and preparation method and application thereof | |
CN115784995A (en) | Isotopic psychoactive substance labeled compound, preparation method and application thereof | |
CN115160254A (en) | Chiral fluorescent probe with benzothiazole group and preparation and application thereof | |
CN114671795B (en) | Indole compounds, preparation method and application in detection of aldehydes and ketones | |
CN114315721A (en) | A kind of photoaffinity link chain and its synthesis method and application | |
CN118702631A (en) | A stable isotope labeling reagent for terminal alkyne compounds and its synthesis and application | |
CN115894377A (en) | Isotope psychoactive substance labeling compound and its preparation method and use | |
CN110357911B (en) | Brassinosteroid derivatization reagent and preparation method and application thereof | |
JP7669323B2 (en) | Estrogen derivatization method, mass spectrometry method, derivatization reagent, and derivatization reagent kit | |
CN100551914C (en) | The chemical synthesis method of albendazole sulfone | |
CN116332992A (en) | Synthesis and application of quaternary phosphonium hydrazide oligosaccharide mass spectrometry derivatization reagents | |
CN115286533B (en) | Laser analysis ionization mass spectrum matrix and preparation method and application thereof | |
CN117800893A (en) | Indolecarboxylic acid compounds, mixtures of indolecarboxylic acid compounds, and analytical methods | |
CN116068110B (en) | Synthesis and application of azide mass spectrometry probe | |
JP2023142295A (en) | New compounds, derivatization compositions for mass spectrometry, and derivatization kits for mass spectrometry | |
JP2023142296A (en) | New compounds, derivatization compositions for mass spectrometry, and derivatization kits for mass spectrometry | |
CN115369430A (en) | Synthetic method of 3-aminomethyl imidazo [1,2-a ] pyridine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201225 |